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Previous studies have shown that calcineurin activity plays a critical role in the myotoxic activity induced by crotoxin (CTX), a group II
phospholipase A2 (PLA2) with neurotoxic and myotoxic actions. In order to address whether calcineurin is also important for the activity of non-
neurotoxic group II PLA2 myotoxins we have compared the effects of calcineurin inhibition on the myotoxic capacity of CTX and the non-
neurotoxic PLA2s, myotoxin II (Mt II) and myotoxin III (Mt III) from Bothrops asper venom. Rats were treated with cyclosporin A (CsA) or
FK506, calcineurin inhibitors, and received an intramuscular injection of either CTX, Mt II or Mt III into the tibialis anterior. Animals were killed
24 h after injection of toxins. Tibialis anterior was removed and stored in liquid nitrogen. Myofibers in culture were also treated with CsA or
FK506 and exposed to CTX, Mt II and Mt III. It was observed that, in contrast to CTX, CsA and FK506 do not attenuate myotoxic effects induced
by both Mt II and Mt III in vivo and in vitro. The results of the present study suggest that calcineurin is not essential for the myotoxic activity of
Mt II and Mt III, indicating that distinct intracellular pathways might be involved in myonecrosis induced by neurotoxic CTX and non-neurotoxic
Bothrops sp. PLA2 myotoxins. Alternatively, calcineurin dependent fast fiber type shift might render the muscle resistant to the action of CTX,
without affecting its susceptibility to Bothrops sp. myotoxins.
© 2006 Elsevier Inc. All rights reserved.Keywords: Crotoxin; Bothrops asper; Myotoxins II and III; Phospholipase A2; Calcineurin; Skeletal muscle injury1. Introduction
Secretory phospholipases A2 (sPLA2s) are enzymes that
catalyze the hydrolysis of the sn-2 acyl bond of glyceropho-
spholipids, in a calcium-dependent fashion, generating free fatty
acids and lysophospholipids (Six and Dennis, 2000). These
enzymes are widely distributed in pancreatic secretions,
inflammatory exudates, and in snake and arthropod venoms
(Balsinde et al., 1999) and in some invertebrates (Nevalainen et
al., 2004a,b; Foradori et al., 2005). A variety of actions are
attributed to venom sPLA2s, which include neurotoxic,⁎ Corresponding author. Tel.: +55 11 30917311; fax: +55 11 30917402.
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doi:10.1016/j.cbpc.2006.03.002myotoxic, edema-inducing, platelet-aggregating, cardiotoxic
and anticoagulant effects (Gutierrez and Lomonte, 1995; Arni
and Ward, 1996; Lomonte et al., 2003b). Venom sPLA2s belong
to groups I (terrestrial elapids and sea snake venoms), II (viperid
snake venoms) and III (bee and lizard venoms) (Six and Dennis,
2000; Valentin and Lambeau, 2000). Group II sPLA2s include,
from the pharmacological standpoint, neurotoxic and non-
neurotoxic types (Mebs and Ownby, 1990).
A well-characterized example of neurotoxic sPLA2 myo-
toxin is crotoxin (CTX), a venom component of the South
American rattlesnake Crotalus durissus terrificus (Hendon
and Fraenkel-Conrat, 1971; Mebs and Ownby, 1990; Salvini
et al., 2001). Among the non-neurotoxic sPLA2 myotoxins,
two different types are currently described: the “classical”
Asp-49 PLA2s, which catalyze the hydrolysis of the ester
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dependent manner; and the “variant” Lys-49 PLA2s which
have been described as devoid of enzymatic activity due to
replacement of Asp-49 by Lys, together with other modifica-
tions in the calcium-binding loop (Lomonte et al., 2003b).
Although unable to hydrolyze the ester bond in the sn-2
position of glycerophospholipids, a host of studies have
shown evidence that Lys-49 PLA2s are able to destabilize cell
membranes by catalytically independent mechanisms (Rufini
et al., 1992; Falconi et al., 2000; Ward et al., 2002; Lomonte
et al., 2003b).
Myotoxins II (Mt II) and III (Mt III) are well-characterized
Lys-49 and Asp-49 myotoxic PLA2s, respectively, present in
Bothrops asper venom (Kaiser et al., 1990; Francis et al., 1991;
Gutierrez and Lomonte, 1995). Similar myotoxic PLA2s have
been described in many Bothrops sp. venoms (Gutierrez and
Lomonte, 1995). Although it is well accepted that most of the
skeletal muscle fiber deleterious effects of Mt II and Mt III are a
direct result of cell membrane damage (delta-lesions, hypercon-
traction of myofilaments, mitochondrial swelling, flocculent
densities and rupture of mitochondrial membranes, disruption
of intracellular membranes and pycnosis of nuclei) (Gutierrez
and Ownby, 2003), it is reasonable to consider that these
proteins might also trigger specific intracellular biochemical
pathways that lead to cell modifications in structure and
function.
In fact it has been recently shown that calcineurin, a Ca2+-
calmodulin-dependent phosphatase, is important for myotoxi-
city driven by a neurotoxic sPLA2, CTX (Miyabara et al.,
2004a), involving nitric oxide production (Miyabara et al.,
2004b). This phosphatase has been involved in muscle
differentiation (Abbott et al., 1998), fiber type determination
(Chin et al., 1998) and hypertrophy (Musaro et al., 1999).
Calcineurin binds to and activates nuclear factor of activated T
cells (NFAT) (Rao et al., 1997; Crabtree, 1999), which targets
the nucleus, dimerizes with other nuclear factors and modulates
transcription of target genes (Rao et al., 1997).
In order to get further insight on the molecular mechanisms
involved in sPLA2 action in skeletal muscle we decided to
investigate whether other PLA2s are also influenced by
calcineurin pharmacological inhibition. We have used Mt II
and Mt III (isolated from the venom of B. asper) as
representatives of Lys-49 and Asp-49 PLA2 subtypes, respec-
tively, which differently from CTX are non-neurotoxic proteins
in vivo (Lomonte et al., 2003a). The results show that, in
contrast with CTX, the calcineurin inhibitors CsA and FK506
do not attenuate myotoxic effects induced by both B. asper
myotoxins.
2. Materials and methods
The protocols used in this study are in agreement with
ethical principles in animal research followed by the Brazilian
College of Animals Experimentation (COBEA) and were
approved by the Institute of Biomedical Sciences/University
of Sao Paulo—Ethical Committee for animals research
(CEEA).2.1. In vivo experiments
2.1.1. Animals
Sixty maleWistar rats weighing 195±6 g were used. The rats
were at random divided into twelve groups (n=5 for each
group) and housed in standard plastic cages in an animal room
with controlled environmental conditions. Rats received
standard food (Purina® chow) and had ad libitum access to
food and water.
2.1.2. Toxins isolation
CTX was purified from C. durissus terrificus crude venom
by gel filtration chromatography (Landucci et al., 1994), and
analyzed by a tricine–SDS–polyacrylamide gel electrophoresis
(Schagger and von Jagow, 1987).
Mt II and Mt III were isolated by ion-exchange chromatog-
raphy on CM-Sephadex C-25 from B. asper venom of adult
specimens, as previously described by Lomonte and Gutierrez
(1989). A final purification step involving reverse-phase HPLC
on a C8 column was introduced. Homogeneity was demon-
strated by analytical reverse phase HPLC.
2.1.3. Treated groups
Three groups received CsA (Sandimmun®, Novartis,
Switzerland; diluted 1:5 with physiologic saline) that was
intraperitoneally administered, twice a day, at a dose of 10 mg/
kg body weight (b.w.), during 5 days. On the 6th day, each
animal received one intramuscular injection of CTX (0.17 mg/
kg b.w.) or Mt II (0.1 mg/kg b.w.) or Mt III (0.1 mg/kg b.w.) into
the middle belly of the left tibialis anterior (TA) muscle, which
was evaluated 24 h after the toxin injection.
Other three groups received FK506 (Prograf®, Fujisawa,
Ireland) that was intraperitoneally administered, twice a day, at a
dose of 1 mg/kg body weight (b.w.), during 5 days. On the 6th
day, each animal received one intramuscular injection of CTX
(0.17 mg/kg b.w.) or Mt II (0.1 mg/kg b.w.) or Mt III (0.1 mg/kg
b.w.) into the middle belly of the left tibialis anterior (TA)
muscle, which was evaluated 24 h after the toxin injection. The
doses of toxins used in the present study were chosen aiming
significant necrosis in the muscle injected without decrease in
total body weight.
2.1.4. Control groups
Animals received an intramuscular injection of saline (NaCl
0.9%) into the left TA muscle. Other groups were injected only
with CTX (0.17 mg/kg b.w.) or Mt II (0.1 mg/kg b.w.) or Mt III
(0.1 mg/kg b.w.) into the same muscle. All groups were killed
24 h after saline or toxin injections. Finally, other two groups
were treated with CsA alone or FK506 alone at the same period
and doses of the treated groups, but did not receive injection of
toxins.
2.1.5. Histology
Animals were weighed, killed by an overdose of ketamine
and xylazine and the TA muscles were removed, immediately
frozen in molten isopentane and stored in liquid nitrogen.
Frozen muscles were cut through mid-portion (end-plate region)
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CM3050, Germany).
Unfixed histological sections were stained with aqueous
toluidine-blue-borax solution (both 1% w/v) to reveal the
general morphology (Morini et al., 1998; Salvini et al., 1999).
The regions of muscle injuries, in which active macrophages are
present, were localized by the histochemical detection of
lysosomal acid phosphatase activity (ac-phosphatase, Gomori
lead method) (Bancroft, 1996).
2.1.6. Muscle injury
The presence of muscle fiber injury was evaluated by light
microscopy (Nikon Eclipse E600). Muscle damage was
identified by the presence of myonecrotic fibers, such as
hypercontracted fibers, clear areas among the muscle fibers,
which indicated tissue disruption, intracellular vacuoles and cell
infiltration. Presence of ac-phosphatase activity was also
considered as a marker of necrosis and phagocytosis. It is
well known that normal muscle fibers do not have positive ac-
phosphatase reaction, which indicates high concentration of
lysosomes, and is considered an evident proof of tissue necrosis
and phagocytosis (Carpenter and Karpati, 1984).
2.2. In vitro experiments
2.2.1. Primary culture of myofibers
Skeletal muscles from hind limb of neonatal rats (0–4 days
age) were removed and immersed in 5 ml Dulbecco's Modified
Eagle's Medium (DMEM, Gibco), supplemented with 10%
fetal bovine serum (FBS, Cultilab) containing 0.2% collagenase
(type I; Gibco) for 3 h at 37 °C (Bischoff, 1986; Liu et al., 1997;
Shefer and Yablonka-Reuveni, 2005). After dissociation,
myofibers were maintained in DMEM 10% FBS, penicillin
(100 U/ml) and streptomycin (0.1 mg/ml) in a humified
atmosphere with 5% CO2, at 37 °C. Myofibers were
standardized in 24-well plates, in which each well was coated
with 30 μl phosphate buffer saline (PBS) containing laminin
(1 μg/μl; Sigma).
2.2.2. Treatments
After establishment of myofibers, they were incubated with
DMEM 10% FBS containing CsA (10−6 M) or FK 506
(10−6 M) for 24 h. Then, the myofibers were exposed to CTX
(133 ng/μl; n=3 wells) or Mt II (133 ng/μl; n=3 wells) or Mt III
(133 ng/μl, n=3 wells) for 3 h.
2.2.3. Myofiber membrane damage
Membrane damage induced by CTX, Mt II and Mt III was
assessed by cytochemistry using a fixable membrane woundTable 1
TA/body weight ratio in controls and injured groups expressed as percentage
Controls Injured CsA+
Saline 0.17±0.02 CTX 0.25±0.01⁎⁎ CTX+
CsA 0.18±0.01 Mt II 0.24±0.04⁎ Mt II
FK506 0.18±0.02 Mt III 0.25±0.03⁎⁎ Mt III
Results are mean±standard deviation; n=5 for each group; ⁎p<0.01 vs. saline; ⁎⁎pmarker (FITC-dx 10,000 M.W., Sigma) as previously described
(Clarke et al., 1994; Clarke and Feeback, 1996).
2.3. Quantitative analysis
The amount of TA necrosed myofibers in tissue sections was
expressed as necrosed myofibers/mm2 (N.M./mm2). The data
was obtained by analyzing digital images acquired by
Metamorph® software (Universal Imaging Corporation, Down-
ingtown, PA, USA).
In cell culture experiments, myofiber alterations were
classified in two ways: (a) the number of damaged myofibers
(i.e. fibers FITC-dx positive) in primary cultures was expressed
as mean percentage of 50 counted fibers per well (total of 150
fibers per group). The data was obtained by analyzing digital
images acquired by a confocal microscope (Nikon Eclipse TE
300, Japan). The number of intact myofibers (intact) in culture
was obtained by using a light and confocal microscope. (b) The
percentage of dead myofibers (dead) in culture was obtained by
the following equation: dead=[T− (I+FITC-dx)]/T. T means
the total number of myofibers before the incubation of toxins; I
means intact (FITC-dx negative) myofibers after incubation
with toxins. By using these two patterns of myofiber alteration,
it was possible to detect fibers that had alterations in plasma
membrane permeability but have not disappeared (FITC-dx
positive) and cells that were in a more advanced stage of
degeneration that were not stained with FITC-dx and had
disappeared by microscopic analysis.
2.4. Statistical analysis
Multiple comparisons of mean values were performed with
analysis of variance (ANOVA) and a post-hoc Tukey's test to
compare mean values when appropriate. Significant level
accepted was below 5% (p<0.05).
3. Results
3.1. In vivo experiments
Mt II, Mt III and CTX induced significant rise in TA/body
weight ratio as compared to their respective controls (41%, 47%
and 47%, p<0.05, respectively; Table 1). As expected, CsA
alone and FK506 alone did not promote significant alterations
in TA/body weight ratio (Table 1). The TA muscle weights from
animals treated with CsA or FK506 and injected with Mt II, Mt
III and CTX were also increased in comparison to their controls
[70% (MtII+CsA), 58% (MtIII+CsA) and 35% (CTX+CsA);
65% (MtII+FK506), 35% (MtIII+FK506) and 59% (CTXInjured FK506+Injured
CsA 0.23±0.02⁎ CTX+FK506 0.27±0.03⁎⁎
+CsA 0.29±0.01⁎⁎ Mt II+FK506 0.28±0.02⁎⁎
+CsA 0.27±0.03⁎⁎ Mt III+FK506 0.23±0.02⁎
<0.001 vs. saline.
Fig. 1. Cross-sections of the middle belly of TA muscles. In animals injected with saline or treated with CsA during 6 days (A and B, respectively) the TA muscle had
normal morphology. (C and D) TA injected with CTX and analyzed after 24 h. (E and F) TA treated with CsA and injected with CTX. (G and H) TA treated with FK506
and injected with CTX. Sections were stained with either toluidine blue (A, B, C, E, G) or acid-phosphatase (D, F, H). Note the presence of clear areas among the
muscle fibers, which result from the muscle fiber disruption and edema (C, D) and several necrotic fibers with cell infiltration (arrows; C, E, G) are positive to ac-
phosphatase reaction, which indicate presence of necrosis and macrophages in process of phagocytosis (arrows; D, F, H). TA muscles treated with CsA or FK506 and
injected with CTX had minimal cell infiltration (E, G) and positive ac-phosphatase reaction (F, H). Bar: 50 μm.
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differences were found when compared to that from animals
receiving only Mt II, Mt III and CTX.
TA muscles from control groups injected with saline or
treated only with CsA had normal morphology, with no signals
of lesion (Fig. 1A, B). Also, the muscles from animals treated
only with FK506 had no signals of injury (data not shown).
CTX was able to induce edema, tissue disruption and
myonecrosis in TA muscles injected with CTX as observed
by the presence of clear spaces among muscle fibers with
inflammatory cells, hypercontracted fibers (Fig. 1C) and several
necrotic fibers positive to ac-phosphatase reaction (Fig. 1D). On
the other hand, TA muscles pre-treated with CsA or FK506 and
injured with CTX showed minimal cell infiltration (Fig. 1E, F,Fig. 2. Serial cross-sections of TA muscles. (A, B) Muscles only injected with Mt II.
with FK506 and injured with Mt II. (A, C, E) Toluidine blue staining and (B, D, F) ac
signals of injury to the group treated with CsA or FK506 and injured with Mt II (C, D
infiltration and necrosed myofibers (arrow; A, C, E) with positive ac-phosphatase reG, H), in comparison with muscles from rats only injected with
CTX (Fig. 1C, D). In addition, pre-treatment with CsA and
FK506 decreased significantly the number of necrosed fibers of
muscle injured by CTX, as assessed by ac-phosphatase
reactions (∼80% and 59% as compared to controls, p<0.05;
Fig. 4).
Mt II and Mt III, in contrast to CTX, neither damaged nor
altered the wet weight of the muscles neighboring the injected
TA muscle, such as soleus and extensor digitorum longus (data
not shown), confirming the restricted nature of the myotoxicity
induced by these myotoxins (Gutierrez and Ownby, 2003). Figs.
2 and 3 show the results of experiments using Mt II and Mt III,
respectively. The TA muscles injected with Mt II or Mt III
showed empty spaces among the muscle fibers, cell infiltration(C, D) Muscles treated with CsA and injured with Mt II. (E, F) Muscles treated
-phosphatase reaction. The muscles only injected with Mt II (A, B) show similar
, E, F): clear spaces among the muscle fibers (A, B, C, D, E, F), intense cellular
action (arrow; B, D, F). Bar: 50 μm.
Fig. 3. Serial cross-sections of TA muscles. (A, B) Muscles only injected with Mt III. (C, D) Muscles treated with CsA and injured with Mt III. (E, F) Muscles treated
with FK506 and injured with Mt III. (A, C, E) Toluidine blue staining and (B, D, F) ac-phosphatase reaction. The muscles only injected with Mt III (A, B) show similar
signals of injury to the group treated with CsA or FK506 and injured with Mt III (C, D, E, F): clear spaces among the muscle fibers (A, B, C, D, E, F), intense cellular
infiltration and necrosed myofibers (arrow; A, C, E) with positive ac-phosphatase reaction (arrow; B, D, F). Bar: 50 μm.
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(Figs. 2A, B and 3A, B, respectively). Interestingly, the muscles
pre-treated with CsA or FK506 and injured with Mt II or Mt III
also had similar signs of lesion as compared to the groups
injected only with Mt II and Mt III, i.e. presence of edema and
myonecrosis (Figs. 2C, D, E, F and 3C, D, E, F, respectively).
The amount of necrosis, expressed as necrosed fibers per mm2
(N.M./mm2), from muscles of rats pre-treated with CsA or
FK506 and injected with Mt II or Mt III were also not different
from those groups only injured with Mt II and Mt III (Fig. 4).
3.2. In vitro experiments
As expected, the isolated myofibers treated only with CsA or
FK506 did not have membrane injury as assessed by FITC-dxlabeling (data not shown). CTX, on the other hand, was able to
induce myofiber membrane damage and myofiber death (27%
and 62% respectively, relative to total number of cells before
treatment, Fig. 5). Pre-treatment with CsA and FK506 decreased
significantly the amount of dead and FITC-dx positive
myofibers exposed to CTX as compared to the group exposed
only with CTX (43% and 29% respectively, p<0.05; Fig. 5).
Similarly to CTX, Mt II induced myofiber membrane
damage and myofiber death (Mt II: 29% and 68%, respectively;
Fig. 6). Interestingly, pre-treatment with CsA or FK506 and
incubation with Mt II had similar amount of dead and FITC-dx
positive myofibers as compared to groups only exposed to Mt II
(Fig. 6).
Mt III induced higher amount of myofiber membrane
damage than myofiber death (80% and 20% respectively, Fig.
Fig. 4. Necrosed myofibers/mm2 in the injected (CTX, Mt II and Mt III) and treated with CsA or FK506 and injected groups (CTX+CsA, Mt II+CsA, Mt III+CsA,
CTX+FK506, Mt II+FK506, Mt III+FK506). Note the drastic reduction of myotoxic activity of CTX in the presence of CsA and FK506; differently, CsA and FK506
have no effect on the myotoxic activity of Mt II and Mt III.
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damaged and dead myofibers as compared to the group only
exposed to Mt III (Fig. 7).
4. Discussion
The present study shows that pre-treatment with CsA or
FK506 leads to a significant minimization of injury in TA
muscles and myofibers exposed to CTX, a neurotoxicFig. 5. (a) Confocal images of primary myofibers in culture stained with FITC-dx ex
respectively). (b) Comparison of percent of dead, FITC-dx positive and intact myofib
and exposed to CTX (CTX+CSA and CTX+FK506; respectively). Data are expresheterodimeric PLA2. On the other hand, pre-treatment with
these calcineurin inhibitors does not have any protective
effect upon skeletal muscles and myofibers exposed to the
non-neurotoxic B. asper PLA2 myotoxins (Mt II and Mt III).
We have used CsA and FK506, in order to exclude the
possibility that the effects described herein are due to other
effects of these drugs not related to calcineurin inhibition.
FK506 has distinct molecular structure as compared to CsA,
however it binds to the same surface of calcineurin (Huai etposed to CTX (A), treated with CsA or FK506 and exposed to CTX (B and C,
ers in culture in the groups treated with CTX (CTX), treated with CsA or FK506
sed as mean±S.D.; n=3–4 wells; ⁎p<0.05 vs. matched CTX.
Fig. 6. (a) Confocal images of primary myofibers in culture stained with FITC-dx exposed to Mt II (A), treated with CsA or FK506 and exposed to Mt II (B and C,
respectively). (b) Comparison of percent of dead, FITC-dx positive and intact myofibers in culture in the groups treated with Mt II (Mt II), treated with CsA or FK506
and exposed to Mt II (Mt II+CSA and Mt II+FK506; respectively). Data are expressed as mean±S.D.; n=3–4 wells.
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lower concentration as compared to CsA (Liu et al., 1991).
The doses of CsA and FK506 utilized in the present work in
vivo (20 and 2 mg/kg/day b.w., respectively) and in vitro
(10−6 M) have been previously studied and are able to
significantly reduce calcineurin activity (∼60%) (Lai et al.,
1998; Dunn et al., 1999; Friday et al., 2000; Dunn et al.,
2001; Serrano et al., 2001; Miyabara et al., 2005). Calcineurin
inhibition by CsA (Fig. 1B) drives no histological signals of
skeletal muscle injury such as necrosed fibers and cellular
infiltration. Similar results were obtained when rats were
injected with FK506 (data not shown). Accordingly, TA/body
weight ratio is also not altered in CsA and FK506 treated
animals (Table 1).
As expected, at 24 h after injection of CTX, Mt II and Mt III
the TA/body weight ratio was increased as compared to control,
indicating that these myotoxins induced an inflammatory
process and consequently edema (Table 1). In addition, both
CsA and FK506 were not able to significantly reduce TA/body
weight ratio induced by Mt II, Mt III and CTX in TA muscles
(Table 1), indicating that the dose of CsA and FK506
administered were not high enough to elicit an anti-inflamma-
tory effect in a severely injured muscle.
Our results show that the three myotoxins tested in this work
promoted efficient injury in TA muscle and membrane damage
in isolated myofibers in culture. Although the histological signsresulting from intramuscular injection of these myotoxins result
in similar damage, these PLA2s have different characteristics in
their toxicological profile. It is well known that CTX is
classified as a basic neurotoxic PLA2 myotoxin because it acts
on the neuromuscular junction, primarily at a presynaptic level,
inhibiting the release of the neurotransmitter acetylcholine
(ACh) (Harris, 1991); consequently its lethal dose 50% (LD50)
value is extremely low. On the other hand, Mt II and Mt III are
non-neurotoxic PLA2 myotoxins that display high LD50 values
(Gutierrez et al., 1986; Gutierrez and Lomonte, 1995). CTX
and Bothrops sp. PLA2 myotoxins also have differences
regarding their ability to induce local and systemic muscle
damage (Gutierrez and Ownby, 2003). CTX is able to induce
muscle damage not only in the injected muscle (local
myotoxicity), but also in muscles remotely located (systemic
myotoxicity) (Salvini et al., 2001). In contrast, Mt II and Mt III
only induce local myotoxicity. These distinct effects might be
due to the specificity of these myotoxins for differentiated
muscle cells, i.e. on their affinity for highly specific targets in
muscle cell plasma membrane (Gutierrez and Ownby, 2003)
and also for targeting other cell types (Lomonte et al., 1994,
1999).
The data showing that both myonecrosis and cytotoxicity
induced by neurotoxic PLA2 myotoxin (CTX) were inhibited by
CsA treatment, combined with no myoprotective effect of CsA
in damaging induced by non-neurotoxic PLA2 myotoxins (Mt II
Fig. 7. (a) Confocal images of primary myofibers in culture stained with FITC-dx exposed to Mt III (A), treated with CsA or FK506 and exposed to Mt III (B and C,
respectively). (b) Comparison of percent of dead, FITC-dx positive and intact myofibers in culture in the groups treated with Mt III (Mt III), treated with CsA or FK506
and exposed to Mt III (Mt III+CSA and Mt III+FK506; respectively). Data are expressed as mean±S.D.; n=3–4 wells.
292 E.H. Miyabara et al. / Comparative Biochemistry and Physiology, Part C 143 (2006) 284–294and Mt III), raise the possibility that different intracellular
pathways mediate myonecrotic effects of CTX and B. asper
PLA2 myotoxins. As previously demonstrated (Miyabara et al.,
2004a), pretreatment with CsA allows a myoprotective effect in
muscles injected with CTX, indicating that calcineurin is
important for myotoxicity driven by CTX, involving nitric
oxide production (Miyabara et al., 2004b).
Although the molecular basis underlying the differential
dependence of these myotoxic PLA2s on calcineurin is still
unknown, several possibilities could be envisioned to explain
this difference: (a) CTX, and related neurotoxic PLA2s, may
bind to receptors in skeletal muscle plasma membrane, such as
the M-type PLA2 receptor (Lambeau and Lazdunski, 1999),
thus promoting intracellular signaling pathways leading to
calcineurin activation, whereas the action of B. asper
myotoxins is likely to depend on a direct damage to the
integrity of sarcolemma. (b) The heterodimeric nature of CTX
might play a role in the calcineurin dependent myotoxic effect;
accordingly, subunit A might be somehow involved in cal-
cineurin activation. (c) Since calcineurin is involved in muscle
fiber type determination (Chin et al., 1998), our results may
reflect the different specificity of these PLA2s toward different
fiber types. CTX and other neurotoxic PLA2 myotoxins have
preference for type I fibers (Harris et al., 1975; Salvini et al.,
2001), whereas types I and II fibers present a similar
susceptibility to a viperid Lys-49 myotoxic PLA2 (Morini et
al., 1998). From this perspective, the effect of calcineurinwould not depend on activation of intracellular degenerative
mechanisms, but instead would be related with fiber type
determination. (d) Another possibility might include the
propagation of a signal in a CsA-sensitive manner, starting
from CTX binding to myofibers leading to cell death. Both Mt
II and Mt III would not trigger such process, therefore the
degree of damage would not be affected by CsA. In fact
certain cytokines, such as interleukin-1β, can be secreted by
muscle cells to act as an endocrine/paracrine signal (Curfs et
al., 1997) to induce cell damage and are dependent on cal-
cineurin (Ho et al., 1996). (e) Finally, it should be taken in
consideration that CTX is able to exert myotoxicity system-
ically, while Mt II and Mt III promote myolesion restricted to
the injected muscle, which could contribute to the differences
in sensitivity to CsA.
A primary goal of this study was to assess whether the
protective effect of calcineurin inhibition against CTX injection
in skeletal muscle depends on the in vivo context. We have
chosen to isolate and culture skeletal muscle myofibers because,
in contrast to permanent lines such as C2C12 cells (Lomonte et
al., 1999), CTX promotes severe plasma membrane damage as
detected by FITC-dx labeling, then leading to disappearance of
cell structure (Fig. 5a). The results clearly show that addition of
CsA or FK506 to the cultures markedly decreases the
proportion of dead cells as a result of CTX treatment. These
results show that the in vivo context is not necessary for the
protective effects of calcineurin inhibition on skeletal fiber
293E.H. Miyabara et al. / Comparative Biochemistry and Physiology, Part C 143 (2006) 284–294damage caused by CTX. As expected from the in vivo findings,
Mt II and Mt III damaging effects were not altered by
calcineurin inhibition, reinforcing the idea that the calcineurin
pathway is specifically activated by CTX and not by these non-
neurotoxic PLA2s.
The data of the present work, combined with two pre-
vious publications (Miyabara et al., 2004a,b) highlight that
although the gross effect of CTX and Bothrops sp. myotoxic
PLA2s in muscle cells is similar, including early cell mem-
brane destruction (Gopalakrishnakone et al., 1984; Gutierrez
et al., 1984) that leads to similar histological signals of
lesion, specific intracellular pathways might also be activa-
ted, leading to different outcomes at the molecular level. These
differential effects might explain differences in potency, site
of action (muscle vs. nervous system) and extent of myo-
toxicity (local vs. systemic). Accordingly, elucidation of such
intracellular pathways activated by PLA2s might provide
useful information on muscle degeneration mechanisms,
which, in turn, may be helpful for the development of fu-
ture therapeutic approaches to be employed in neuromuscular
diseases.
In conclusion, the results presented herein show that
calcineurin is an essential pathway mediating CTX myotoxicity
in vivo and in vitro, which might be specific since calcineurin
inhibitors do not attenuate muscle damage induced by other
myotoxins such as B. asper Mt II and Mt III.
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